Related Experiment Videos

[Tumor markers in lymphoproliferative disorders]

¹Department of Medicine, National Cancer Center Hospital East.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|June 1, 1996

Summary

This review classifies tumor markers for lymphoproliferative disorders, finding them useful for prognosis and monitoring treatment. Future molecular techniques will enable detection of specific tumor markers in clinical settings.

Area of Science:

Oncology
Hematology
Biochemistry

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Rapid weight gain during early childhood is associated with overweight in preadolescence: a longitudinal study in Japan.

Child: care, health and development·2016

Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.

British journal of cancer·2010

A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.

Annals of oncology : official journal of the European Society for Medical Oncology·2002

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study.

Annals of oncology : official journal of the European Society for Medical Oncology·2002

Re-treatment of relapsed indolent B-cell lymphoma with rituximab.

International journal of hematology·2001

See all related articles